Physician profile
Tm Hughes, III
NPI 1801819933
$159.27
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $28.84.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $60.22 | 2019 | |
| Fresenius USA Marketing, INC. | $35.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.26 | 2019 | |
| Akebia Therapeutics INC | $15.39 | 2020 | |
| Astellas Pharma US INC | $14.30 | 2019 | |
| Opko Pharmaceuticals, LLC | $13.45 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tm Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.